Odisha signs MoU for establishment of GMP facility for production of Anthrax and ENT Vaccines
Odisha government today signed a MoU today with National Dairy Development Board (NDDB) for establishing GMP facility for production of Anthrax and ENT Vaccines at Satellite Unit, OBPI (Odisha Biological Products Institute) in Berhampur.
Bhubaneswar: Odisha government today signed a MoU today with National Dairy Development Board (NDDB) for establishing GMP facility for production of Anthrax and ENT Vaccines at Satellite Unit, OBPI (Odisha Biological Products Institute) in Berhampur.
The agreement was signed was signed by Ramashis Hazra, Director, AH & VS and Sunil Sinha, Senior General Manager, NDDB in presence of Ranendra Pratap Swain, Minister Agriculture & Farmers Empowerment, Fisheries and ARD.
Speaking on the occasion, Minister Swain said that establishment of this unit will make our State, self sufficient in production of Anthrax and Enterotoxaemia Vaccine. Further, meeting its own requirement the State will also be able to supply vaccines to other States.
The project has been taken up as 5-T Charter initiative to transform the healthcare and disease management of livestock and poultry in the State. At present, the existing satellite unit of OBPI at Berhampur is producing 22 lakh doses of Anthrax Spore Vaccine (ASV) and 14 Lakh doses of Enterotoxaemia Vaccine (ENTV) annually in conventional method.
Establishment of Good Manufacturing Practice (GMP) laboratory will comply with WHO norms, and the Drugs and Cosmetics Act 1940 of India and production of world calss quality vaccine. On operational of this 2.00 Crores and 50 Lakhs doses of ENTV and ASV vaccines will be produced respectively.
An amount of Rs. 52 Crore will be utilized for establishment of the Unit. NDDB will provide consultancy, supervisory services for setting up of the GMP unit, along with completion of the trial runs and final commissioning of the Plant. The construction work of laboratory will be completed within 36 months. Establishment of GMP Laboratory will create a state-of-art laboratory producing Anthrax and ENT Vaccines, which will be one of the unique facilities of its kind in the country.
Ms Kalinga